Transition from post-capillary pulmonary hypertension to combined pre- and post-capillary pulmonary hypertension in swine: a key role for endothelin

被引:28
作者
van Duin, Richard W. B. [1 ]
Stam, Kelly [1 ]
Cai, Zongye [1 ]
Uitterdijk, Andre [1 ]
Garcia-Alvarez, Ana [2 ,3 ]
Ibanez, Borja [2 ,4 ,5 ]
Danser, A. H. Jan [6 ]
Reiss, Irwin K. M. [7 ]
Duncker, Dirk J. [1 ]
Merkus, Daphne [1 ]
机构
[1] Erasmus MC, Thoraxctr, Dept Cardiol, Div Expt Cardiol, Rotterdam, Netherlands
[2] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain
[3] IDIBAPS, Hosp Clin Barcelona, Barcelona, Spain
[4] IIS Fdn Jimenez Diaz Univ Hosp, Madrid, Spain
[5] CIBERCV, Madrid, Spain
[6] Erasmus MC, Dept Pharmacol, Rotterdam, Netherlands
[7] Erasmus MC, Sophia Childrens Hosp, Pediat Neonatol, Rotterdam, Netherlands
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2019年 / 597卷 / 04期
关键词
pulmonary hypertension; endothelin; translational study; CHRONIC HEART-FAILURE; CLINICAL-TRIALS UPDATE; ETA-RECEPTOR BLOCKADE; EXERCISING SWINE; VASCULAR-RESISTANCE; SCIENTIFIC SESSIONS; DIFFUSION CAPACITY; OF-CARDIOLOGY; UP-REGULATION; BLOOD-FLOW;
D O I
10.1113/JP275987
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Passive, isolated post-capillary pulmonary hypertension (IpcPH) secondary to left heart disease may progress to combined pre- and post-capillary or active' PH (CpcPH) characterized by chronic pulmonary vascular constriction and remodelling. The mechanisms underlying this activation' of passive pulmonary hypertension (PH) remain incompletely understood. Here we investigated the role of the vasoconstrictor endothelin-1 (ET) in the progression from IpcPH to CpcPH in a swine model for post-capillary PH. Swine underwent pulmonary vein banding (PVB; n=7) or sham-surgery (Sham; n=6) and were chronically instrumented 4weeks later. Haemodynamics were assessed for 8weeks, at rest and during exercise, before and after administration of the ET receptor antagonist tezosentan. After sacrifice, the pulmonary vasculature was investigated by histology, RT-qPCR and myograph experiments. Pulmonary arterial pressure and resistance increased significantly over time. mRNA expression of prepro-endothelin-1 and endothelin converting enzyme-1 in the lung was increased, while ETA expression was unchanged and ETB expression was downregulated. This was associated with increased plasma ET levels from week 10 onward and a more pronounced vasodilatation to in vivo administration of tezosentan at rest and during exercise. Myograph experiments showed decreased endothelium-dependent vasodilatation to Substance P and increased vasoconstriction to KCl in PVB swine consistent with increased muscularization observed with histology. Moreover, maximal vasoconstriction to ET was increased whereas ET sensitivity was decreased. In conclusion, PVB swine gradually developed PH with structural and functional vascular remodelling. From week 10 onward, the pulmonary ET pathway was upregulated, likely contributing to pre-capillary activation of the initially isolated post-capillary PH. Inhibition of the ET pathway could thus potentially provide a pharmacotherapeutic target for early stage post-capillary PH.
引用
收藏
页码:1157 / 1173
页数:17
相关论文
共 70 条
[1]   Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model [J].
Aguero, Jaume ;
Ishikawa, Kiyotake ;
Hadri, Lahouaria ;
Santos-Gallego, Carlos ;
Fish, Kenneth ;
Hammoudi, Nadjib ;
Chaanine, Antoine ;
Torquato, Samantha ;
Naim, Charbel ;
Ibanez, Borja ;
Pereda, Daniel ;
Garcia-Alvarez, Ana ;
Fuster, Valentin ;
Sengupta, Partho P. ;
Leopold, Jane A. ;
Hajjar, Roger J. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 307 (08) :H1204-H1215
[2]   Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH):: randomised, double-blind, placebo-controlled trial [J].
Anand, I ;
McMurray, J ;
Cohn, JN ;
Konstam, MA ;
Notter, T ;
Quitzau, K ;
Ruschitzka, F ;
Lüscher, TF .
LANCET, 2004, 364 (9431) :347-354
[3]   Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension [J].
Bauer, M ;
Wilkens, HC ;
Langer, F ;
Schneider, SO ;
Lausberg, H ;
Schäfers, HJ .
CIRCULATION, 2002, 105 (09) :1034-1036
[4]   BETA-ADRENERGIC NEUROEFFECTOR ABNORMALITIES IN THE FAILING HUMAN HEART ARE PRODUCED BY LOCAL RATHER THAN SYSTEMIC MECHANISMS [J].
BRISTOW, MR ;
MINOBE, W ;
RASMUSSEN, R ;
LARRABEE, P ;
SKERL, L ;
KLEIN, JW ;
ANDERSON, FL ;
MURRAY, J ;
MESTRONI, L ;
KARWANDE, SV ;
FOWLER, M ;
GINSBURG, R .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :803-815
[5]   Endothelial dysfunction in pulmonary hypertension [J].
Budhiraja, R ;
Tuder, RM ;
Hassoun, PM .
CIRCULATION, 2004, 109 (02) :159-165
[6]   Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component [J].
Caravita, Sergio ;
Faini, Andrea ;
Deboeck, Gael ;
Bondue, Antoine ;
Naeije, Robert ;
Parati, Gianfranco ;
Vachiery, Jean-Luc .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (07) :754-762
[7]   PLASMA ENDOTHELIN CORRELATES WITH THE EXTENT OF PULMONARY-HYPERTENSION IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE [J].
CODY, RJ ;
HAAS, GJ ;
BINKLEY, PF ;
CAPERS, Q ;
KELLEY, R .
CIRCULATION, 1992, 85 (02) :504-509
[8]   Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology - WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME [J].
Coletta, AP ;
Cleland, JGF .
EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (06) :747-750
[9]   The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure [J].
Cooper, CJ ;
Jevnikar, FW ;
Walsh, T ;
Dickinson, J ;
Mouhaffel, A ;
Selwyn, AP .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (05) :609-614
[10]   Upregulation of endothelial nitric oxide synthase and endothelin-1 in pulmonary hypertension secondary to heart failure in aorta-banded rats [J].
Dai, ZK ;
Tan, MS ;
Chai, CY ;
Yeh, JL ;
Chou, SH ;
Chiu, CC ;
Jeng, AY ;
Chen, IJ ;
Wu, JR .
PEDIATRIC PULMONOLOGY, 2004, 37 (03) :249-256